#4A;(2R*,3S*)-2-(4-BROMOBENZOYL)-3-MORPHOLINO-2-PHENYLOXETANE-3-CARBONITRILE;#6A;(2R*,3S*)-2-BENZOYL-2-(4-BROMOPHENYL)-3-MORPHOLINOOXETANE-3-CARBONITRILE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | I96gArvqklw |
|---|---|
| InChI | InChI=1S/2C21H19BrN2O3/c22-18-8-6-16(7-9-18)19(25)21(17-4-2-1-3-5-17)20(14-23,15-27-21)24-10-12-26-13-11-24;22-18-8-6-17(7-9-18)21(19(25)16-4-2-1-3-5-16)20(14-23,15-27-21)24-10-12-26-13-11-24/h2*1-9H,10-13,15H2/t2*20-,21+/m00/s1 |
| InChIKey | UYYSAIJJFRLTBI-LNTGIPEPSA-N |
| Mol Weight | 854.6 g/mol |
| Molecular Formula | C42H38Br2N4O6 |
| Exact Mass | 852.115811 g/mol |
| Enantiomer InChIKey | UYYSAIJJFRLTBI-KVFZLMDDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-Benzyl-2-phenylindolizin-1-ylacetic acid
9-Acridanone, 1,4-dihydroxy-2,3-dimethoxy-10-methyl-
CULARIDINE-METHIODIDE
2-(3,4-DIMETHOXYPHENYL)-6-METHOXY-2-(PHENYLTHIO)-BENZOFURAN-3(2H)-ONE
acetamide, 2-[[3-cyano-4-(2-furanyl)-1,4,5,6,7,8-hexahydro-5-oxo-2-quinolinyl]thio]-N-(2,4,6-trimethylphenyl)-
(3Z)-1-acetyl-3-[(6-benzoxy-7-methyl-1,3-benzodioxol-5-yl)methylene]-6-(4-methoxy-3-methyl-benzyl)piperazine-2,5-quinone
8-(isopropylsulfanyl)-1,3-dimethyl-7-(1-naphthylmethyl)-3,7-dihydro-1H-purine-2,6-dione
3-Benzyl-5',5'-dimethyl-9-bromo-2,3,4,4a,5,6-hexahydro-1H-spiro[benzo[c]quinolizine-5,2'-cyclohexane]-1',3'-dione
2H-indazol-3-amine, N,2-bis(4-chlorophenyl)-4,6-dinitro-, 1-oxide
1-DIMETHYLAMINO-2-METHOXYCARBONYL-4A-METHYL-6-HYDROXY-1,2,3,4,4A,9A-HEXAHYDROBENZOFURO[2,3-B]PYRIDINE
| Title | Journal or Book | Year |
|---|---|---|
| [2+2]-Photocycloaddition of 2-Morpholinopropenenitrile to Monosubstituted Benzils | Monatshefte f�r Chemie / Chemical Monthly | 2004 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.